Sight Sciences EVP Raheja exits insider status

Sight Sciences, Inc. filed an insider report indicating that EVP of Research & Development Manohar K. Raheja is no longer a Section 16 insider.

Rhea-AI Filing Summary

Sight Sciences, Inc. filed an insider report indicating that EVP of Research & Development Manohar K. Raheja is no longer a Section 16 insider. Effective August 31, 2025, his employment with the company terminated.

Because of this change, he will no longer be required to report transactions in Sight Sciences equity securities on Form 4 or Form 5. The filing does not list any specific stock transactions in its tables, focusing instead on the change in his reporting status.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Form 4 for Sight Sciences (SGHT) disclose?

The Form 4 discloses a change in insider status. It states that EVP of Research & Development Manohar K. Raheja’s employment ended effective August 31, 2025, so he is no longer a Section 16 insider required to report equity transactions.

Who is the reporting person in the Sight Sciences (SGHT) Form 4?

The reporting person is Manohar K. Raheja. He is identified as an officer of Sight Sciences, serving as Executive Vice President, Research & Development, and is no longer subject to Section 16 reporting after his employment ended on August 31, 2025.

Does the Sight Sciences (SGHT) Form 4 show any stock transactions?

The Form 4 does not list any specific stock trades. The non-derivative and derivative transaction tables contain no reported acquisitions or dispositions, and the key disclosure instead centers on the end of the officer’s employment and Section 16 reporting obligations.

When did Manohar K. Raheja’s employment with Sight Sciences (SGHT) end?

His employment ended effective August 31, 2025. The remarks section clearly states that as of that date, his employment with Sight Sciences terminated, which also ends his status as a Section 16 reporting person for the company’s equity securities.

Why will Manohar K. Raheja no longer file Forms 4 or 5 for Sight Sciences (SGHT)?

He will no longer file because he is no longer a Section 16 insider. The filing explains that his employment terminated on August 31, 2025, so he is no longer subject to Section 16 in connection with transactions in the company’s equity securities.

What is Manohar K. Raheja’s former role at Sight Sciences (SGHT)?

He served as EVP, Research & Development. The Form 4 identifies him as an officer with the title Executive Vice President, Research & Development, before his employment ended and his obligation to file Section 16 reports ceased on August 31, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/03/2025 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Raheja Manohar K.

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Research & Development

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Effective August 31, 2025, the Reporting Person's employment with the Issuer terminated. As a result, the Reporting Person is no longer subject to Section 16 in connection with his transactions in the equity securities of the Issuer and therefore will no longer report any such transactions on Form 4 or Form 5.

	/s/ Jeremy Hayden, Attorney-in-Fact for Manohar K. Raheja	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.